SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL, Leonidou A, Wai P, Marchiò C, Ng CK, Sapino A, Salomon AV, Reis-Filho JS, Weigelt B, Natrajan RC.
Maguire SL, et al. Among authors: leonidou a.
J Pathol. 2015 Mar;235(4):571-80. doi: 10.1002/path.4483. Epub 2014 Dec 22.
J Pathol. 2015.
PMID: 25424858
Free PMC article.